Variant report
Variant | esv3324566 |
---|---|
Chromosome Location | chr14:104393824-104396372 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:26)
- CpG islands (count:428)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:26 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CHD2 | chr14:104394557-104395284 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr14:104394223-104394259 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr14:104394521-104394607 | Hela-S3 | cervix: | n/a | n/a |
4 | CTCF | chr14:104394000-104394210 | HRE | kidney: | n/a | n/a |
5 | E2F6 | chr14:104394552-104395015 | H1-hESC | embryonic stem cell: | n/a | chr14:104394715-104394729 chr14:104394792-104394804 chr14:104394617-104394627 chr14:104394755-104394764 |
6 | E2F6 | chr14:104394607-104394991 | H1-hESC | embryonic stem cell: | n/a | chr14:104394715-104394729 chr14:104394792-104394804 chr14:104394617-104394627 chr14:104394755-104394764 |
7 | E2F6 | chr14:104394490-104395125 | Hela-S3 | cervix: | n/a | chr14:104394715-104394729 chr14:104394792-104394804 chr14:104394617-104394627 chr14:104394755-104394764 chr14:104395069-104395078 |
8 | HCFC1 | chr14:104394314-104395181 | Hela-S3 | cervix: | n/a | n/a |
9 | MAX | chr14:104394475-104394955 | Hela-S3 | cervix: | n/a | chr14:104394523-104394532 |
10 | MAX | chr14:104393709-104393964 | K562 | blood: | n/a | chr14:104393901-104393910 |
11 | MAZ | chr14:104394844-104394952 | Hela-S3 | cervix: | n/a | n/a |
12 | MXI1 | chr14:104394650-104394907 | Hela-S3 | cervix: | n/a | n/a |
13 | NFYA | chr14:104394551-104394899 | Hela-S3 | cervix: | n/a | n/a |
14 | NFYB | chr14:104394601-104395027 | Hela-S3 | cervix: | n/a | n/a |
15 | NFYB | chr14:104394575-104394849 | K562 | blood: | n/a | n/a |
16 | POLR2A | chr14:104394475-104395117 | Hela-S3 | cervix: | n/a | n/a |
17 | POLR2A | chr14:104395427-104395434 | MCF-7 | breast: | n/a | n/a |
18 | POLR2A | chr14:104395512-104395515 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr14:104395435-104395510 | MCF-7 | breast: | n/a | n/a |
20 | POLR2A | chr14:104394696-104395045 | Hela-S3 | cervix: | n/a | n/a |
21 | POLR2A | chr14:104394646-104395016 | Hela-S3 | cervix: | n/a | n/a |
22 | POLR2A | chr14:104394707-104395045 | Hela-S3 | cervix: | n/a | n/a |
23 | RFX5 | chr14:104394471-104394852 | Hela-S3 | cervix: | n/a | n/a |
24 | SMC3 | chr14:104394569-104394608 | Hela-S3 | cervix: | n/a | n/a |
25 | TBP | chr14:104394805-104394871 | Hela-S3 | cervix: | n/a | n/a |
26 | ZNF143 | chr14:104394457-104394805 | Hela-S3 | cervix: | n/a | chr14:104394620-104394638 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104394621-104394671 | HIPEpiC | eye: | n/a |
2 | chr14:104394621-104394671 | HIPEpiC | eye: | n/a |
3 | chr14:104394430-104394480 | NH-A | brain: | n/a |
4 | chr14:104395485-104395535 | GM19239 | blood: | n/a |
5 | chr14:104394430-104394480 | AoSMC | blood vessel: | n/a |
6 | chr14:104394621-104394671 | GM19239 | blood: | n/a |
7 | chr14:104395165-104395215 | HRCEpiC | kidney: | n/a |
8 | chr14:104394831-104394881 | AoSMC | blood vessel: | n/a |
9 | chr14:104395165-104395215 | SKMC | muscle: | n/a |
10 | chr14:104394621-104394671 | AoSMC | blood vessel: | n/a |
11 | chr14:104394621-104394671 | HEEpiC | esophagus: | n/a |
12 | chr14:104395429-104395479 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr14:104394831-104394881 | HepG2 | liver: | n/a |
14 | chr14:104394621-104394671 | HCF | heart: | n/a |
15 | chr14:104394430-104394480 | A549 | lung: | n/a |
16 | chr14:104395485-104395535 | T-47D | breast: | n/a |
17 | chr14:104395485-104395535 | LNCaP | prostate: | n/a |
18 | chr14:104395485-104395535 | AG04449 | skin: | fetal |
19 | chr14:104394530-104394580 | PrEC | prostate: | n/a |
20 | chr14:104395165-104395215 | HRPEpiC | eye: | n/a |
21 | chr14:104395429-104395479 | AG04450 | lung: | fetal |
22 | chr14:104395165-104395215 | BJ | skin: | n/a |
23 | chr14:104395485-104395535 | HMEC | breast: | n/a |
24 | chr14:104394621-104394671 | SKMC | muscle: | n/a |
25 | chr14:104394530-104394580 | HPAEpiC | pulmonary alveolar: | n/a |
26 | chr14:104395165-104395215 | HNPCEpiC | eye: | n/a |
27 | chr14:104394430-104394480 | ECC-1 | luminal epithelium: | n/a |
28 | chr14:104395429-104395479 | HRPEpiC | eye: | n/a |
29 | chr14:104394831-104394881 | HL-60 | blood: | n/a |
30 | chr14:104394831-104394881 | IMR90 | lung: | fetal |
31 | chr14:104394430-104394480 | AG09309 | skin: | n/a |
32 | chr14:104394831-104394881 | Hepatocyte | liver: | n/a |
33 | chr14:104394621-104394671 | AG10803 | skin: | n/a |
34 | chr14:104395429-104395479 | AG09309 | skin: | n/a |
35 | chr14:104394621-104394671 | PFSK-1 | brain: | n/a |
36 | chr14:104395165-104395215 | LNCaP | prostate: | n/a |
37 | chr14:104394530-104394580 | PFSK-1 | brain: | n/a |
38 | chr14:104394831-104394881 | ProgFib | skin: | n/a |
39 | chr14:104394621-104394671 | Hepatocyte | liver: | n/a |
40 | chr14:104394621-104394671 | NHBE | bronchial: | n/a |
41 | chr14:104395165-104395215 | PANC-1 | pancreas: | n/a |
42 | chr14:104394831-104394881 | H1-hESC | embryonic stem cell: | embryo |
43 | chr14:104395485-104395535 | U87 | brain: | n/a |
44 | chr14:104394430-104394480 | HEK293 | kidney: | embryo |
45 | chr14:104394530-104394580 | U87 | brain: | n/a |
46 | chr14:104394831-104394881 | HNPCEpiC | eye: | n/a |
47 | chr14:104395165-104395215 | AG04450 | lung: | fetal |
48 | chr14:104395485-104395535 | GM12878 | blood: | n/a |
49 | chr14:104395165-104395215 | HepG2 | liver: | n/a |
50 | chr14:104395485-104395535 | NHBE | bronchial: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104393603..104397064-chr14:104407702..104410726,3 | K562 | blood: | |
2 | chr14:104391863..104393842-chr14:104396870..104399828,2 | K562 | blood: | |
3 | chr14:104395726..104398249-chr14:104421446..104423004,2 | K562 | blood: | |
4 | chr14:104387638..104390416-chr14:104390451..104394175,4 | K562 | blood: | |
5 | chr14:104385710..104388983-chr14:104393675..104397966,4 | MCF-7 | breast: | |
6 | chr14:104159423..104160385-chr14:104396350..104397254,2 | MCF-7 | breast: | |
7 | chr14:104393603..104396242-chr14:104407114..104410000,4 | K562 | blood: | |
8 | chr14:104379142..104381534-chr14:104393675..104395664,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TDRD9 | TF binding region |
C14orf2 | TF binding region |
TDRD9 | CpG island |
C14orf2 | CpG island |
ENSG00000227729 | chromatin interactions |
ENSG00000156411 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72712871 | chr14:104393891-104393892 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74548289 | chr14:104393903-104393904 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs190449168 | chr14:104393905-104393906 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs1040812 | chr14:104393932-104393933 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs8014519 | chr14:104393947-104393948 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs183391985 | chr14:104393990-104393991 | ZNF genes & repeats Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs561611715 | chr14:104394000-104394001 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs545893481 | chr14:104394004-104394005 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs73352428 | chr14:104394035-104394036 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs540273417 | chr14:104394049-104394050 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs560604425 | chr14:104394092-104394093 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs140677218 | chr14:104394094-104394095 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs145748280 | chr14:104394102-104394103 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs115365255 | chr14:104394144-104394145 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs536267147 | chr14:104394199-104394200 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs74086759 | chr14:104394210-104394211 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs28563863 | chr14:104394230-104394231 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs533733891 | chr14:104394238-104394239 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs562796190 | chr14:104394270-104394271 | ZNF genes & repeats Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs547094478 | chr14:104394317-104394318 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs374528698 | chr14:104394340-104394341 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs375698382 | chr14:104394386-104394387 | ZNF genes & repeats Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs370067446 | chr14:104394424-104394425 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs187850754 | chr14:104394432-104394433 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs10149651 | chr14:104394440-104394441 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs372311010 | chr14:104394459-104394460 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs144284991 | chr14:104394468-104394469 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs555257081 | chr14:104394548-104394549 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs148307886 | chr14:104394556-104394557 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs141396018 | chr14:104394572-104394573 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionCpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs560269207 | chr14:104394590-104394591 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs192364024 | chr14:104394599-104394600 | ZNF genes & repeats Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs545887384 | chr14:104394634-104394635 | Weak transcription Enhancers Active TSS | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs113602507 | chr14:104394638-104394639 | Weak transcription Enhancers Active TSS | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs562682555 | chr14:104394667-104394668 | Weak transcription Enhancers Active TSS | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs531362452 | chr14:104394699-104394700 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs530246903 | chr14:104394754-104394755 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs113496080 | chr14:104394774-104394775 | Weak transcription Enhancers Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs9324065 | chr14:104394835-104394836 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs9324066 | chr14:104394850-104394851 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs184390484 | chr14:104394879-104394880 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs187691561 | chr14:104394894-104394895 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs539463501 | chr14:104394897-104394898 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs549865389 | chr14:104394911-104394912 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs569772232 | chr14:104394944-104394945 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs538416055 | chr14:104394982-104394983 | Weak transcription Active TSS Bivalent/Poised TSS Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs112776471 | chr14:104395048-104395049 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs376931720 | chr14:104395108-104395109 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs555214454 | chr14:104395154-104395155 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
50 | rs368783260 | chr14:104395156-104395157 | Weak transcription Active TSS Bivalent/Poised TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104390200-104395400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr14:104392200-104395200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
3 | chr14:104392400-104395600 | Weak transcription | HepG2 | liver |
4 | chr14:104393800-104394600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr14:104394400-104395800 | Active TSS | Hela-S3 | cervix |
6 | chr14:104394600-104395000 | Enhancers | Spleen | Spleen |
7 | chr14:104394600-104398200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr14:104394800-104395000 | Enhancers | Pancreas | Pancrea |
9 | chr14:104394800-104395200 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr14:104394800-104395200 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr14:104394800-104395200 | Bivalent/Poised TSS | Fetal Brain Female | brain |
12 | chr14:104394800-104395200 | Bivalent/Poised TSS | Stomach Smooth Muscle | stomach |
13 | chr14:104395000-104401200 | Weak transcription | Spleen | Spleen |
14 | chr14:104395200-104395600 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr14:104395200-104395600 | Bivalent/Poised TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr14:104395200-104395600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr14:104395400-104396200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr14:104395400-104399400 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr14:104395600-104395800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
20 | chr14:104395600-104397200 | Enhancers | HepG2 | liver |
21 | chr14:104395600-104398200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
22 | chr14:104395800-104396000 | Flanking Active TSS | Hela-S3 | cervix |
23 | chr14:104395800-104396200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
24 | chr14:104396000-104396200 | Active TSS | Hela-S3 | cervix |
25 | chr14:104396200-104396600 | Flanking Active TSS | Hela-S3 | cervix |
26 | chr14:104396200-104397000 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
27 | chr14:104396200-104397200 | Enhancers | Primary B cells from cord blood | blood |
28 | chr14:104396200-104399800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |